First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 775 000 KRW 0.65% Market Closed
Updated: Apr 29, 2024

Samsung Biologics Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Samsung Biologics Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
P
087010
K
278650
S
237690
F
220100
L
141080

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Samsung Biologics Co Ltd
KRX:207940
Cash from Operating Activities
₩1.7T
CAGR 3-Years
102%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Cash from Operating Activities
-₩11B
CAGR 3-Years
7%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Cash from Operating Activities
₩5.2B
CAGR 3-Years
-23%
CAGR 5-Years
9%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Cash from Operating Activities
₩1.3B
CAGR 3-Years
N/A
CAGR 5-Years
-34%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Cash from Operating Activities
-₩3.7B
CAGR 3-Years
-18%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Cash from Operating Activities
-₩62.2B
CAGR 3-Years
-61%
CAGR 5-Years
-37%
CAGR 10-Years
-26%

See Also

What is Samsung Biologics Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.7T KRW

Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Cash from Operating Activities amounts to 1.7T KRW.

What is Samsung Biologics Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
102%

Over the last year, the Cash from Operating Activities growth was 75%. The average annual Cash from Operating Activities growth rates for Samsung Biologics Co Ltd have been 102% over the past three years .